Skip to main content
. 2020 Jul 24;105(10):e3730–e3741. doi: 10.1210/clinem/dgaa478

Figure 1.

Figure 1.

Height SD from the mean (HtSDS) at baseline before GH therapy (GHT) and after 5 years of GHT in GH-deficient childhood cancer survivors, according to tumor subgroup. SDS, SD score.